Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience
| Authors | |
|---|---|
| Year of publication | 2008 |
| Type | Article in Periodical |
| Magazine / Source | Journal of Thoracic Oncology |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | non-small cell lung cancer; advanced cancer; treatmetment; erlotinib |
| Description | A single-instution experience is presented of Erlotinib (Tarceva) used to treat patients with advanced non-small lung cancer (NSCLC). |
| Related projects: |